Webinar Optimizing Clinical Trial Design

Quick Overview: ABSTRACT: Rare diseases are characterized by their low prevalence (e.g., 1 in 2000 people in Europe). According to Orphanet, a ... In this video Customer Consultant drug safety Jean-Dominique Pierret and Drug Safety Marketing Manager Dr. Marnix Wieffer will ... Okay the other main reason that we were building this disease progression model is to allow it to a inform our

Webinar Optimizing Clinical Trial Design - Detailed Overview & Context

ABSTRACT: Rare diseases are characterized by their low prevalence (e.g., 1 in 2000 people in Europe). According to Orphanet, a ... In this video Customer Consultant drug safety Jean-Dominique Pierret and Drug Safety Marketing Manager Dr. Marnix Wieffer will ... Okay the other main reason that we were building this disease progression model is to allow it to a inform our ... which we'll get into shortly so uh big picture study Let's see it seems like we're doing pretty good on time so uh recent Trends in This video describes the work of the Duchenne Regulatory Science Consortium that has collaborated on the development of a ...

Daniel Lewi, Founder of the CATS Foundation, and Kathleen Flynn, CEO of the National Tay-Sachs & Allied Diseases Association ... Tuesday, June 20th, 2023 Moderators: Sepideh Gholami MD Northwell Health Akhil Chawla MD Northwestern University. Recent advancements in the development and approval of novel anti-obesity drugs hold much promise and have reinvigorated ... Join us for an exclusive panel discussion with industry leaders from Lindus Health and Harbinger Health as we explore the ...